Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Halstenson

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
The Annals of Pharmacotherapy|December 1, 1993
New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitorsE F Foote, C E Halstenson
Drug Intelligence & Clinical Pharmacy|November 1, 1983
Bumetanide: a new loop diuretic (Bumex, Roche Laboratories)C E Halstenson, G R Matzke
DICP : the Annals of Pharmacotherapy|July 1, 1989
Recombinant human erythropoietinM H Schwenk, C E Halstenson
Antimicrobial Agents and Chemotherapy|April 4, 1998
Effects of probenecid and cimetidine on renal disposition of ofloxacin in ratsE F Foote, C E Halstenson
Journal of Clinical Pharmacology|March 1, 1987
Gentamicin disposition in young and elderly patients with various degrees of renal functionG R Matzke, J J Jameson, C E Halstenson
Antimicrobial Agents and Chemotherapy|January 1, 1984
Hemodialysis elimination rates and clearance of gentamicin and tobramycinG R Matzke, C E Halstenson, W F Keane
Therapeutic Drug Monitoring|July 1, 1991
Hemodialysis clearance of encainide and metabolitesM B Halvorsen, J T Whitmer, C E Halstenson
American Journal of Hypertension|November 1, 1989
Antihypertensive and humoral effects of nifedipine in essential hypertension uncontrolled by hydrochlorothiazide aloneJ A Opsahl, C E Halstenson, P A Abraham
Annals of Emergency Medicine|May 1, 1991
Whole-bowel irrigation as a treatment for acute lithium overdoseS W Smith, L J Ling, C E Halstenson
Pharmacotherapy|January 1, 1991
Antipyrine plasma and urine metabolite disposition with lorazepam coadministrationJ V St Peter, C E Halstenson, W M Awni
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
The Annals of Pharmacotherapy|December 1, 1993
New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitorsE F Foote, C E Halstenson
Drug Intelligence & Clinical Pharmacy|November 1, 1983
Bumetanide: a new loop diuretic (Bumex, Roche Laboratories)C E Halstenson, G R Matzke
DICP : the Annals of Pharmacotherapy|July 1, 1989
Recombinant human erythropoietinM H Schwenk, C E Halstenson
Antimicrobial Agents and Chemotherapy|April 4, 1998
Effects of probenecid and cimetidine on renal disposition of ofloxacin in ratsE F Foote, C E Halstenson
Journal of Clinical Pharmacology|March 1, 1987
Gentamicin disposition in young and elderly patients with various degrees of renal functionG R Matzke, J J Jameson, C E Halstenson
Antimicrobial Agents and Chemotherapy|January 1, 1984
Hemodialysis elimination rates and clearance of gentamicin and tobramycinG R Matzke, C E Halstenson, W F Keane
Therapeutic Drug Monitoring|July 1, 1991
Hemodialysis clearance of encainide and metabolitesM B Halvorsen, J T Whitmer, C E Halstenson
American Journal of Hypertension|November 1, 1989
Antihypertensive and humoral effects of nifedipine in essential hypertension uncontrolled by hydrochlorothiazide aloneJ A Opsahl, C E Halstenson, P A Abraham
Annals of Emergency Medicine|May 1, 1991
Whole-bowel irrigation as a treatment for acute lithium overdoseS W Smith, L J Ling, C E Halstenson
Pharmacotherapy|January 1, 1991
Antipyrine plasma and urine metabolite disposition with lorazepam coadministrationJ V St Peter, C E Halstenson, W M Awni
Pageof 9